Evaxion Biotech
Regulatory Status Disclosed
Overview
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-Immunologyu2122 platform
- Personalized cancer vaccine development
- Infectious disease vaccine development
- Target discovery within 24 hours
- Drug design and development
- Clinically validated AI prediction models
- Multidisciplinary R&D capabilities
- Scalable AI platform
Use Cases
- Decoding the human immune system
- Developing novel vaccine candidates for cancer
- Developing novel vaccine candidates for infectious diseases
- Rapid target discovery for vaccine development
- Precision drug design for immunotherapies
- Partnering for vaccine development
Details
| Category | Drug Discovery & Research, Lab & Diagnostics |
| Pricing | Unknown |
| Deployment | Cloud |
| Mobile App | None |
| API Available | No |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Unknown |
| FDA Status | Not applicable AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Allergy & Immunology, Infectious Disease, Oncology |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Evaxion Biotech
No press coverage or publications on file yet.
Know of some? Suggest an edit →
Videos
Product demos, reviews, and walkthroughs for Evaxion Biotech.
Loading videos...
No FAQs available yet for this tool.
Suggest an Edit → | Report an issue
| Last Verified: 2026-11-09 | First Added: 2026-11-08





